| Primary |
| Hypercholesterolaemia |
60.0% |
| Osteomyelitis |
40.0% |
|
| Rhabdomyolysis |
83.3% |
| Blood Creatine Phosphokinase Increased |
16.7% |
|
| Secondary |
| Product Used For Unknown Indication |
11.7% |
| Osteomyelitis |
11.4% |
| Staphylococcal Infection |
9.2% |
| Myocardial Ischaemia |
8.0% |
| Infection |
7.3% |
| Hypercholesterolaemia |
6.8% |
| Diabetes Mellitus |
6.7% |
| Arthritis Bacterial |
6.1% |
| Cardiovascular Event Prophylaxis |
5.0% |
| Drug Use For Unknown Indication |
4.3% |
| Ischaemic Ulcer |
3.8% |
| Blood Cholesterol Increased |
3.4% |
| Device Related Infection |
2.7% |
| Localised Infection |
2.7% |
| Cardiac Failure Congestive |
2.4% |
| Hypertension |
2.4% |
| Atrial Fibrillation |
1.6% |
| Pneumonia |
1.6% |
| Wound Infection |
1.4% |
| Septic Arthritis Staphylococcal |
1.2% |
|
| Rhabdomyolysis |
40.2% |
| Drug Interaction |
6.2% |
| Urinary Tract Infection |
6.2% |
| Myopathy |
5.2% |
| Staphylococcal Infection |
5.2% |
| Tachypnoea |
5.2% |
| Vomiting |
4.1% |
| Paraparesis |
3.1% |
| Tracheal Haemorrhage |
3.1% |
| Pain In Extremity |
2.6% |
| Sepsis |
2.6% |
| Multiple-drug Resistance |
2.1% |
| Muscular Weakness |
2.1% |
| Myocardial Infarction |
2.1% |
| Potentiating Drug Interaction |
2.1% |
| Renal Failure Acute |
2.1% |
| Asthenia |
1.5% |
| Drug Intolerance |
1.5% |
| Haemodialysis |
1.5% |
| Hallucination, Visual |
1.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
39.4% |
| Drug Use For Unknown Indication |
21.2% |
| Hypertension |
5.2% |
| Pruritus |
4.0% |
| Diffuse Large B-cell Lymphoma |
3.3% |
| Gastroenteritis |
3.1% |
| Nasopharyngitis |
2.8% |
| Diarrhoea |
2.6% |
| Upper Respiratory Tract Infection |
2.4% |
| Insomnia |
2.1% |
| Head And Neck Cancer |
1.7% |
| Hypercholesterolaemia |
1.6% |
| Device Related Infection |
1.4% |
| Thyroid Cancer |
1.4% |
| Central Nervous System Lymphoma |
1.3% |
| Conjunctivitis |
1.3% |
| Constipation |
1.3% |
| Pain |
1.3% |
| Cheilitis |
1.1% |
| Hepatitis C |
1.1% |
|
| Rhabdomyolysis |
13.1% |
| Pain In Extremity |
8.3% |
| Convulsion |
6.0% |
| Fall |
6.0% |
| Myalgia |
6.0% |
| Rash Erythematous |
6.0% |
| Drug Intolerance |
4.8% |
| Pain |
4.8% |
| Skin Ulcer |
4.8% |
| Wernicke-korsakoff Syndrome |
4.8% |
| Anaphylactic Reaction |
3.6% |
| Bone Marrow Failure |
3.6% |
| Deafness Neurosensory |
3.6% |
| Depression |
3.6% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.6% |
| Gastrointestinal Haemorrhage |
3.6% |
| Haematocrit Increased |
3.6% |
| International Normalised Ratio Increased |
3.6% |
| Jaundice |
3.6% |
| Oesophageal Varices Haemorrhage |
3.6% |
|
| Interacting |
| Osteomyelitis |
15.5% |
| Staphylococcal Infection |
12.0% |
| Drug Use For Unknown Indication |
8.1% |
| Blood Cholesterol Increased |
6.4% |
| Arthritis Bacterial |
5.6% |
| Localised Infection |
4.8% |
| Septic Arthritis Staphylococcal |
4.8% |
| Myocardial Ischaemia |
4.6% |
| Hypercholesterolaemia |
4.1% |
| Pain |
3.8% |
| Product Used For Unknown Indication |
3.8% |
| Wound Infection Staphylococcal |
3.6% |
| Arthritis |
3.3% |
| Antibiotic Resistant Staphylococcus Test Positive |
3.1% |
| Arthroscopy |
3.1% |
| Chest Pain |
2.8% |
| Hyperlipidaemia |
2.8% |
| Osteoarthritis |
2.8% |
| Diabetes Mellitus |
2.5% |
| Infection |
2.5% |
|
| Rhabdomyolysis |
54.3% |
| Sepsis |
11.0% |
| Drug Interaction |
6.3% |
| Vomiting |
3.9% |
| Hepatitis Acute |
3.1% |
| Knee Arthroplasty |
3.1% |
| Urinary Tract Infection |
3.1% |
| Jaundice |
2.4% |
| Asthenia |
1.6% |
| Hypotension |
1.6% |
| Myalgia |
1.6% |
| Weight Decreased |
1.6% |
| Alanine Aminotransferase Increased |
0.8% |
| Anuria |
0.8% |
| Cardiac Murmur |
0.8% |
| Diarrhoea |
0.8% |
| Dysphagia |
0.8% |
| Enterococcal Infection |
0.8% |
| International Normalised Ratio Increased |
0.8% |
| Mobility Decreased |
0.8% |
|
